EBIT (Annual)

EBIT: Income before interest and taxes.

Pharming Group N.V. Sponsored ADR (PHAR) had EBIT of $25.84M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$376.13M
Net Income	$2.85M
Cost of Goods Sold	$45.50M
Gross Profit	$330.63M
Operating Expenses	$350.29M
Operating Income	$25.84M
Non-Operating Income/Expense	$-13.00M
Pre-Tax Income	$12.85M
Normalized Pre-Tax Income	$12.85M
Income after Taxes	$2.54M
Income from Continuous Operations	$2.54M
Consolidated Net Income/Loss	$2.54M
Normalized Income after Taxes	$2.54M
EBIT	$25.84M
EBITDA	$37.06M
Weighted-Average Shares Outstanding (Basic)	68.88M
Weighted-Average Shares Outstanding (Diluted)	74.69M
Earnings per Share (EPS) (Basic)	$0.04
Earnings per Share (EPS) (Diluted)	$0.04
Balance Sheet Financials
Current Assets	$299.47M
Property, Plant, and Equipment	$7.23M
Long-Term Assets	$200.49M
Total Assets	$499.96M
Current Liabilities	$115.79M
Long-Term Debt	$92.72M
Long-Term Liabilities	$107.07M
Total Liabilities	$222.86M
Common Equity	$277.10M
Tangible Shareholders Equity	$141.56M
Shareholders Equity	$277.10M
Common Shares Outstanding	70.17M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$54.71M
Cash Flow from Investing Activities	$26.25M
Cash Flow from Financial Activities	$1.50M
Beginning Cash	$54.94M
End Cash	$145.31M
Increase/Decrease in Cash	$90.36M
Stock-Based Compensation	$13.77M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.59
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.25
Debt to Equity Ratio	0.35
Gross Margin	87.90%
Operating Margin	6.87%
EBIT Margin	6.87%
EBITDA Margin	9.85%
Pre-Tax Profit Margin	3.42%
Profit Margin	0.76%
Free Cash Flow	$53.96M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.75
Inventory Turnover	0.70
Receiveable Turnover	6.88
Days Sales in Receivables	53.08
Return on Equity	0.92%
Return on Tangible Equity	1.79%
Return on Assets	0.51%
Return on Investments	0.69%
Book Value Per Share	$3.95
Free Cash Flow per Share	$0.72
Operating Cash Flow per Share	$0.73

Data from Zacks Investment Research, Inc.